StockNews.AI
SVRA
StockNews.AI
84 days

BREAKING: Savara Shares Down Over 30%; Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

1. Savara's stock plummeted over 30% following FDA application rejection. 2. FDA cited incomplete submission for Biologics License Application review. 3. Block & Leviton is investigating potential securities law violations. 4. Investors can seek recovery for losses through legal actions. 5. Whistleblower program may offer rewards for critical information.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The significant stock decline and FDA rejection heavily impact investor confidence and future funding.

How important is it?

The article directly addresses a critical issue affecting SVRA's valuation and credibility.

Why Short Term?

The immediate effects are observable as stock prices react, but long-term impact depends on resolution.

Related Companies

JNJAMGNVRTX
BOSTON, May 27, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Savara Inc. (Nasdaq: SVRA) for potential securities law violations. Investors who have lost money in their Savara Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/svra. What is this all about? Shares of Savara fell over 30% in intraday trading on May 27, 2025, after the company announced that the FDA issued a Refusal to File letter for its Biologics License Application for Molbreevi, its lead drug candidate for autoimmune PAP. Savara said the FDA found the submission “not sufficiently complete” for review, citing issues with the CMC section of the application. The company was unable to specify what data was missing, or why the deficiencies weren’t addressed prior to submission. Who is eligible? Anyone who purchased Savara Inc. common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more. What is Block & Leviton doing? Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money. What should you do next? If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at shareholders@blockleviton.com, or by phone at (888) 256-2510. Whistleblower? If you have non-public information about Savara Inc., you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at shareholders@blockleviton.com or by phone at (888) 256-2510. Why should you contact Block & Leviton? Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website www.blockleviton.com, call (888) 256-2510 or email shareholders@blockleviton.com with any questions. This notice may constitute attorney advertising. CONTACT:BLOCK & LEVITON LLP260 Franklin St., Suite 1860Boston, MA 02110Phone: (888) 256-2510Email: shareholders@blockleviton.com 

Related News